Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review

Review of 20 studies (1 RCT, total n=5443) concludes that there is significant uncertainty as to whether convalescent plasma is beneficial for people admitted to hospital with COVID‐19 in terms of time to death or improvement in clinical symptoms.


Cochrane Database of Systematic Reviews